ストックスクリーナーアプリを入手
4.32
0.92%
-0.04
アフターアワーズ：
4.33
0.010
+0.23%
Larimar Therapeutics Inc (LRMR) 最新ニュース
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? - Stocktwits
Hennion & Walsh Asset Management Inc. Purchases New Position in Larimar Therapeutics, Inc. $LRMR - MarketBeat
Dimensional Fund Advisors LP Purchases 470,968 Shares of Larimar Therapeutics, Inc. $LRMR - MarketBeat
Renaissance Technologies LLC Has $3.33 Million Position in Larimar Therapeutics, Inc. $LRMR - MarketBeat
LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns - Stocktwits
Larimar Therapeutics (LRMR) to Announce Earnings on Thursday - marketbeat.com
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Regulatory and Manufacturing Risks Cloud Larimar Therapeutics’ Accelerated Approval Path for Nomlabofusp - The Globe and Mail
William Blair Maintains Larimar Therapeutics(LRMR.US) With Buy Rating - Moomoo
LRMR Maintained by Wedbush -- Price Target Lowered to $11.00 - GuruFocus
Wedbush Cuts Larimar Therapeutics (NASDAQ:LRMR) Price Target to $11.00 - MarketBeat
LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Larimar Therapeutics (LRMR) Advances Nomlabofusp Submission Amid Mixed Financial Signals - GuruFocus
Larimar Therapeutics 2Q 2026: Net loss $32.8M, Diluted EPS $(0.30) — 10-Q Summary - TradingView
Larimar Therapeutics Reports Positive Longer-Term Nomlabofusp Data and Progress Toward Rolling BLA Submission for Friedreich’s Ataxia - Quiver Quantitative
Larimar: Q2 Earnings Snapshot - marketscreener.com
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update - Yahoo Finance
Larimar Therapeutics (LRMR) Gains 3.27% as Biotech Stock Approaches Key $4.32 ResistanceAnalyst Downgrade Signals - dars.gov.et
SummitTX Capital L.P. Invests $1.71 Million in Larimar Therapeutics, Inc. $LRMR - MarketBeat
Larimar Therapeutics Inc (LRMR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
A Deeper Dive Into Design Therapeutics (NASDAQ:DSGN) - Seeking Alpha
Larimar Therapeutics Inc (LRMR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Larimar Therapeutics Inc (LRMR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Larimar Therapeutics Inc (LRMR) Institutional Confidence - TradingKey
LRMR|Larimar Therapeutics Inc|Price:3.820|Chg%:-0.180 - TradingKey
Enterprise value to EBITDA forward of Larimar Therapeutics, Inc. – NASDAQ:LRMR - TradingView
TradingKey - TradingKey
Larimar Therapeutics Market Sentiment - Benzinga España
Larimar Therapeutics, Inc. Revenue Breakdown – NASDAQ:LRMR - tradingview.com
What Just Happened with Larimar Therapeutics (LRMR) and Why Does it Matter - Kavout | AI
LRMR|Larimar Therapeutics Inc|Price:4.000|Chg%:-0.010 - TradingKey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc.LRMR - PR Newswire
Price to earnings forward of Larimar Therapeutics, Inc. – SWB:ZA71 - TradingView
Larimar Therapeutics Files First Module of BLA for Nomlabofusp in Friedreich's Ataxia TreatmentNew Analyst Coverage - dars.gov.et
Larimar Therapeutics Initiates BLA Submission for Nomlabofusp in Friedreich’s AtaxiaProfit Guidance Range - dars.gov.et
Larimar Therapeutics Files Initial BLA Module for Nomlabofusp in Friedreich's AtaxiaPre-Announcement Alert - dars.gov.et
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy - Yahoo Finance
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Price to earnings forward of Larimar Therapeutics, Inc. – LS:A2P5PP - TradingView
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy - Stocktwits
Price to sales forward of Larimar Therapeutics, Inc. – NASDAQ:LRMR - TradingView
Thomas Hamilton Bought 6.1% More Shares In Larimar Therapeutics - Moomoo
Larimar Therapeutics stock jumps on insider purchase By Investing.com - Investing.com South Africa
Larimar Therapeutics stock jumps on insider purchase - Investing.com
Larimar Therapeutics director buys $166,890 in company stock - Investing.com UK
Enterprise value to revenue forward of Larimar Therapeutics, Inc. – SWB:ZA71 - TradingView
LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000 - TradingView
Larimar Therapeutics director buys $166,890 in company stock By Investing.com - Investing.com South Africa
Form 4 Larimar Therapeutics Inc For: 8 July By Investing.com - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
Larimar Therapeutics (LRMR) director purchases 50,000 common shares - Stock Titan
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):